1. Home
  2. BODI vs ELUT Comparison

BODI vs ELUT Comparison

Compare BODI & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Beachbody Company Inc.

BODI

The Beachbody Company Inc.

N/A

Current Price

$10.91

Market Cap

56.8M

Sector

Industrials

ML Signal

N/A

Logo Elutia Inc.

ELUT

Elutia Inc.

N/A

Current Price

$1.09

Market Cap

46.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BODI
ELUT
Founded
1998
2015
Country
United States
United States
Employees
355
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.8M
46.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BODI
ELUT
Price
$10.91
$1.09
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$9.50
$6.00
AVG Volume (30 Days)
21.3K
183.7K
Earning Date
01-01-0001
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.14
EPS
N/A
N/A
Revenue
N/A
$24,375,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$25.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.38
$0.50
52 Week High
$12.66
$3.46

Technical Indicators

Market Signals
Indicator
BODI
ELUT
Relative Strength Index (RSI) 63.94 52.53
Support Level $10.18 $0.86
Resistance Level $12.66 $1.15
Average True Range (ATR) 0.83 0.13
MACD 0.32 -0.01
Stochastic Oscillator 95.99 16.18

Price Performance

Historical Comparison
BODI
ELUT

About BODI The Beachbody Company Inc.

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: